Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study. (Q43932140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

F Hosseinpanah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

S Ghareh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

M Tohidi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

F Azizi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

1 reference

21 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Nutrition

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

295-299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23963276%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ejcn.2013.142

7 March 2020

exact match

0 references

cites work

Global burden of obesity in 2005 and projections to 2030.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Metabolic and body composition factors in subgroups of obesity: what do we know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Characterizing the profile of obese patients who are metabolically healthy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Open questions about metabolically normal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

The distinction of metabolically 'healthy' from 'unhealthy' obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Predictive power of the components of metabolic syndrome in its development: a 6.5-year follow-up in the Tehran Lipid and Glucose Study (TLGS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Central adiposity determines prevalence differences of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Metabolic normality in overweight and obese subjects. Which parameters? Which risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.142

Diagnostic values of metabolic syndrome definitions for detection of insulin resistance: Tehran Lipid and Glucose Study (TLGS).

21 January 2018

1 reference

12 December 2020

Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire

1 reference

12 December 2020

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

12 December 2020

Metabolically healthy but obese individuals

1 reference

12 December 2020